Kerecis ehf:製品パイプライン分析

GlobalDataが発行した調査報告書(DATA8013776)
◆英語タイトル:Kerecis ehf - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8013776
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年10月27日
◆ページ数:27
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アイスランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura mater repair, breast reconstruction and abdominal wall reconstruction and for surgical stapling. It also develops mOmega3 fatty acid (fish-sourced fatty acids) technology for use in several dermatological indications such as psoriasis, eczema, dermatitis, keratosis pilaris and pseudofolliculitis. Kerecis major products consists of fish-skin acellular dermal matrix products such as Omega3 Wound, Omega3 Dura, Omega3 Hernia, Omega3 Pectus, Omega3 Seal, and topical creams including Smooth with mOmega3, Footguard with mOmega3, Psoria with mOmega3 and Xma with mOmega3. The company uses complete acellular fish skin for tissue regeneration by transplantation. Kerecis is headquartered in Isafjordur, Iceland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Kerecis ehf
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Kerecis ehf Company Overview 4
Kerecis ehf Company Snapshot 4
Kerecis ehf Pipeline Products and Ongoing Clinical Trials Overview 5
Kerecis ehf – Pipeline Analysis Overview 7
Kerecis ehf – Key Facts 7
Kerecis ehf – Major Products and Services 8
Kerecis ehf Pipeline Products by Development Stage 9
Kerecis ehf Pipeline Products Overview 11
Kerecis Omega3 Dura 11
Kerecis Omega3 Dura Product Overview 11
Kerecis Omega3 Hernia 12
Kerecis Omega3 Hernia Product Overview 12
Kerecis Omega3 Pectus 13
Kerecis Omega3 Pectus Product Overview 13
Kerecis Omega3 Wound 14
Kerecis Omega3 Wound Product Overview 14
Kerecis ehf – Key Competitors 15
Kerecis ehf – Key Employees 16
Kerecis ehf – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Kerecis ehf, Recent Developments 18
Mar 22, 2017: PolyMedics Innovations to Sell Kerecis Omega3-rich Fish-Skin Burn Treatment in the U.S. 18
Oct 18, 2016: Kerecis Omega3-rich Fish-Skin Treatment for Wound Treatment to be Introduced to the Asian Market at a Major Medical Congress in Singapore 18
Sep 16, 2016: Kerecis Wound-Treatment Product With Omega3 Fish Skin Now Eligible for Medicare Reimbursement in 45 States 19
Sep 13, 2016: FDA Clears Omega3-rich Fish Skin for Surgical Applications 19
Aug 15, 2016: Studies Show That the Kerecis Fish Skin Reduces Infections and Preserves Tissue Viability 20
Aug 12, 2016: Kerecis Fish Skin Wound Treatment Available for the VA and Other Government Agencies 20
Mar 30, 2016: Kerecis Fish Skin Wound Treatment to Be Available for U.S. Military Veterans 21
Sep 25, 2015: Kerecis Omega3 Fish Skin Wound Grafts Recruit Significantly More Cells than a Leading Amnion Membrane Wound Treatment Brand 21
Aug 17, 2015: Studies on the Kerecis Fish Skin Graft Show That the Product Recruits Stem Cells and Closes Wounds Significantly Faster Than the Leading Competitive Product 22
Mar 23, 2015: Medical Fish Skin Company Kerecis Receives Annual Innovation Through Knowledge Award From President of Iceland 22
Appendix 24
Methodology 24
About GlobalData 26
Contact Us 26
Disclaimer 27

List of Tables
Kerecis ehf Pipeline Products and Ongoing Clinical Trials Overview 5
Kerecis ehf Pipeline Products by Equipment Type 5
Kerecis ehf Pipeline Products by Indication 6
Kerecis ehf, Key Facts 7
Kerecis ehf, Major Products and Services 8
Kerecis ehf Number of Pipeline Products by Development Stage 9
Kerecis ehf Pipeline Products Summary by Development Stage 10
Kerecis Omega3 Dura - Product Status 11
Kerecis Omega3 Dura - Product Description 11
Kerecis Omega3 Hernia - Product Status 12
Kerecis Omega3 Hernia - Product Description 12
Kerecis Omega3 Pectus - Product Status 13
Kerecis Omega3 Pectus - Product Description 13
Kerecis Omega3 Wound - Product Status 14
Kerecis Omega3 Wound - Product Description 14
Kerecis ehf, Key Employees 16
Kerecis ehf, Other Locations 17
Glossary 25

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Kerecis ehf:製品パイプライン分析(Kerecis ehf - Product Pipeline Analysis, 2017 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆